Tai Sandi See, the Chief Development Officer of $LXEO, sold 44 shares of the company on 10-17-2025 for an estimated $420. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.1% of their shares of this class of stock. Following this trade, they now own 65,862 shares of this class of $LXEO stock.
$LXEO Insider Trading Activity
$LXEO insiders have traded $LXEO stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $LXEO stock by insiders over the last 6 months:
- RICHARD NOLAN TOWNSEND (Chief Executive Officer) has made 0 purchases and 4 sales selling 16,942 shares for an estimated $133,182.
- TAI SANDI SEE (Chief Development Officer) has made 0 purchases and 4 sales selling 4,637 shares for an estimated $37,568.
- JENNY ROBERTSON (Chief Legal Officer) has made 0 purchases and 4 sales selling 4,589 shares for an estimated $35,505.
- ERIC ADLER (Chief Medical Officer) has made 0 purchases and 4 sales selling 4,575 shares for an estimated $34,702.
- JOSE MANUEL OTERO (Chief Technical Officer) has made 0 purchases and 3 sales selling 4,963 shares for an estimated $32,207.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LXEO Hedge Fund Activity
We have seen 53 institutional investors add shares of $LXEO stock to their portfolio, and 32 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BALYASNY ASSET MANAGEMENT L.P. added 4,009,137 shares (+inf%) to their portfolio in Q2 2025, for an estimated $16,116,730
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. added 3,469,210 shares (+363.1%) to their portfolio in Q2 2025, for an estimated $13,946,224
- AFFINITY ASSET ADVISORS, LLC added 2,108,474 shares (+142.4%) to their portfolio in Q2 2025, for an estimated $8,476,065
- VESTAL POINT CAPITAL, LP added 2,091,912 shares (+184.1%) to their portfolio in Q2 2025, for an estimated $8,409,486
- MILLENNIUM MANAGEMENT LLC added 1,764,803 shares (+164.7%) to their portfolio in Q2 2025, for an estimated $7,094,508
- WOODLINE PARTNERS LP added 1,735,148 shares (+207.3%) to their portfolio in Q2 2025, for an estimated $6,975,294
- NOVO HOLDINGS A/S removed 1,122,581 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,512,775
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$LXEO Analyst Ratings
Wall Street analysts have issued reports on $LXEO in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Leerink Partners issued a "Outperform" rating on 10/07/2025
- Chardan Capital issued a "Buy" rating on 10/07/2025
- HC Wainwright & Co. issued a "Buy" rating on 10/07/2025
- Oppenheimer issued a "Outperform" rating on 07/31/2025
- JP Morgan issued a "Overweight" rating on 05/30/2025
To track analyst ratings and price targets for $LXEO, check out Quiver Quantitative's $LXEO forecast page.
$LXEO Price Targets
Multiple analysts have issued price targets for $LXEO recently. We have seen 7 analysts offer price targets for $LXEO in the last 6 months, with a median target of $17.0.
Here are some recent targets:
- Debjit Chattopadhyay from Guggenheim set a target price of $30.0 on 10/15/2025
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $15.0 on 10/07/2025
- Geulah Livshits from Chardan Capital set a target price of $17.0 on 10/07/2025
- Mani Foroohar from Leerink Partners set a target price of $20.0 on 10/07/2025
- Leland Gershell from Oppenheimer set a target price of $20.0 on 07/31/2025
- Tessa Romero from JP Morgan set a target price of $10.0 on 05/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
